GSK will not be prosecuted over seroxat/ child suicide

GSK will not be prosecuted over seroxat/ child suicide
Law on drugs tests to be tightened

By Gary Cleland

Last Updated: 8:08am GMT 06/03/2008

Drugs companies must reveal the results of clinical trials as soon as
they uncover potential problems with their medicines, the Government
is expected to announce.

GSK has always denied that it improperly withheld information about
Seroxat
Dawn Primarolo, the health minister, will announce new legislation,
which will be introduced by the end of the year, according to The
Guardian.

The law will ensure that drug companies pass information on the
potentially harmful effects of their medicines to the authorities
immediately.

The move comes after a four-year investigation into how
GlaxoSmithKline (GSK) withheld the full results of their trials into
the anti-depressant Seroxat on children.

The trial data revealed that there was a higher risk of suicidal
behaviour among children younger than 18 on Seroxat than those given
a placebo.


The results also found that Seroxat was ineffective in dealing with
depression in those under 18.

It was handed to the Medicines and Healthcare Regulatory Authority
(MHRA) in May 2003, despite GSK having allegedly been aware of the
results since 1998.

A month later, in June 2003, the MHRA announced that doctors must
stop giving Seroxat to those under 18.

Miss Primarolo will say that GSK should have informed the MHRA
earlier than it did, but that the drugs company will not face
criminal charges.

The MHRA investigation found that the company could have told them
earlier, but did not break the letter of the law by not doing so, as
current legislation is not clear as to when a company should reveal
the results of its clinical trials.

GSK has always denied that it improperly withheld information about
Seroxat.

It said Seroxat was never approved by EU or US regulators for those
under 18 and was never marketed as such.

It also said its trial results were submitted to regulators and were
presented publicly on its website and in journals.

Responses

Messages in this topic (1) Reply (via web post) | Start a new topic

.

So the day I've been expecting for a long time , finally came. They
got away with it.... for now...Poor lost, miguided souls.. As they pop
their expensive champagne and sit back with their gloating smirks
feeling mighty pleased with themselves....patting themselves on the
back, thinking.... oh boy those investments paid off big time...
they've escaped prison...for now...........
When will they learn that there is no escape from taking personal
responsibility...that sooner or later the wheel turns and we all have
to face up to our deeds....the prison of the mind...much worse than
the one with physical bars...
It is a law of nature that for every action, there is an equal and
opposite reaction.....nobody escapes this truth...nobody. No matter
how powerful, no matter how rich..Oh God imagine the reactions coming
their way...

Thanks for the post Jeremy.

Steph

--- In SSRI-Crusaders%40yahoogroups.com">SSRI-Crusadersyahoogroups.com, "bryce_j_j"
<jeremybryce1953...> wrote:
&gt;
> GSK will not be prosecuted over seroxat/ child suicide
> Law on drugs tests to be tightened
>
> By Gary Cleland
>
>
> Last Updated: 8:08am GMT 06/03/2008
>
>
>
>
>
> Drugs companies must reveal the results of clinical trials as soon as
> they uncover potential problems with their medicines, the Government
> is expected to announce.
>
>
> GSK has always denied that it improperly withheld information about
> Seroxat
> Dawn Primarolo, the health minister, will announce new legislation,
> which will be introduced by the end of the year, according to The
> Guardian.
>
> The law will ensure that drug companies pass information on the
> potentially harmful effects of their medicines to the authorities
> immediately.
>
> The move comes after a four-year investigation into how
> GlaxoSmithKline (GSK) withheld the full results of their trials into
> the anti-depressant Seroxat on children.
>
> The trial data revealed that there was a higher risk of suicidal
> behaviour among children younger than 18 on Seroxat than those given
> a placebo.
>
>
>
>
>
> The results also found that Seroxat was ineffective in dealing with
> depression in those under 18.
>
> It was handed to the Medicines and Healthcare Regulatory Authority
> (MHRA) in May 2003, despite GSK having allegedly been aware of the
> results since 1998.
&gt;
> A month later, in June 2003, the MHRA announced that doctors must
> stop giving Seroxat to those under 18.
>
> Miss Primarolo will say that GSK should have informed the MHRA
> earlier than it did, but that the drugs company will not face
> criminal charges.
>
> The MHRA investigation found that the company could have told them
> earlier, but did not break the letter of the law by not doing so, as
> current legislation is not clear as to when a company should reveal
> the results of its clinical trials.
>
> GSK has always denied that it improperly withheld information about
> Seroxat.
>
> It said Seroxat was never approved by EU or US regulators for those
> under 18 and was never marketed as such.
&gt;
> It also said its trial results were submitted to regulators and were
> presented publicly on its website and in journals.
>
>
>
>
>
> Responses
>

Messages in this topic (2) Reply (via web post) | Start a new topic

.

IF I DID THIS I WOULD BE IN JAIL.

How the hell do we get justice when the criminals
can sit behind their corporations and profits and never
be made to take responsibility for their actions?

There has to be a way. I just haven't thought of it yet.
Jim

GSK will not be prosecuted over seroxat/ child suicide
Law on drugs tests to be tightened

By Gary Cleland

Last Updated: 8:08am GMT 06/03/2008

Drugs companies must reveal the results of clinical trials as soon as
they uncover potential problems with their medicines, the Government
is expected to announce.

GSK has always denied that it improperly withheld information about
Seroxat
Dawn Primarolo, the health minister, will announce new legislation,
which will be introduced by the end of the year, according to The
Guardian.

The law will ensure that drug companies pass information on the
potentially harmful effects of their medicines to the authorities
immediately.

The move comes after a four-year investigation into how
GlaxoSmithKline (GSK) withheld the full results of their trials into
the anti-depressant Seroxat on children.

The trial data revealed that there was a higher risk of suicidal
behaviour among children younger than 18 on Seroxat than those given
a placebo.


The results also found that Seroxat was ineffective in dealing with
depression in those under 18.

It was handed to the Medicines and Healthcare Regulatory Authority
(MHRA) in May 2003, despite GSK having allegedly been aware of the
results since 1998.

A month later, in June 2003, the MHRA announced that doctors must
stop giving Seroxat to those under 18.

Miss Primarolo will say that GSK should have informed the MHRA
earlier than it did, but that the drugs company will not face
criminal charges.

The MHRA investigation found that the company could have told them
earlier, but did not break the letter of the law by not doing so, as
current legislation is not clear as to when a company should reveal
the results of its clinical trials.

GSK has always denied that it improperly withheld information about
Seroxat.

It said Seroxat was never approved by EU or US regulators for those
under 18 and was never marketed as such.

It also said its trial results were submitted to regulators and were
presented publicly on its website and in journals.

Responses



Yahoo! Groups Links

Messages in this topic (3) Reply (via web post) | Start a new topic

.